[go: up one dir, main page]

AU2003215687A1 - 1,2,4-triazole derivatives with cannabinoid properties - Google Patents

1,2,4-triazole derivatives with cannabinoid properties

Info

Publication number
AU2003215687A1
AU2003215687A1 AU2003215687A AU2003215687A AU2003215687A1 AU 2003215687 A1 AU2003215687 A1 AU 2003215687A1 AU 2003215687 A AU2003215687 A AU 2003215687A AU 2003215687 A AU2003215687 A AU 2003215687A AU 2003215687 A1 AU2003215687 A1 AU 2003215687A1
Authority
AU
Australia
Prior art keywords
triazole derivatives
cannabinoid
properties
cannabinoid properties
triazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003215687A
Inventor
Ivon Jose Alcorta Osoro
Maria Teresa Dannert
Maria Pilar Goya Laza
Laura Hernandez Folgado
Nadine Jagerovic
Maria Isabel Martin Fontelles
Margarita Linarejos Suardiaz Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Rey Juan Carlos
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Rey Juan Carlos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad Rey Juan Carlos filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Publication of AU2003215687A1 publication Critical patent/AU2003215687A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003215687A 2002-03-27 2003-03-18 1,2,4-triazole derivatives with cannabinoid properties Abandoned AU2003215687A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200200740 2002-03-27
ES200200740A ES2192494B1 (en) 2002-03-27 2002-03-27 1,2,4-TRIAZOL DERIVATIVES WITH CANNABINOID PROPERTIES.
PCT/ES2003/000126 WO2003082833A1 (en) 2002-03-27 2003-03-18 1,2,4-triazole derivatives with cannabinoid properties

Publications (1)

Publication Number Publication Date
AU2003215687A1 true AU2003215687A1 (en) 2003-10-13

Family

ID=28459667

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003215687A Abandoned AU2003215687A1 (en) 2002-03-27 2003-03-18 1,2,4-triazole derivatives with cannabinoid properties

Country Status (3)

Country Link
AU (1) AU2003215687A1 (en)
ES (1) ES2192494B1 (en)
WO (1) WO2003082833A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7129239B2 (en) 2002-10-28 2006-10-31 Pfizer Inc. Purine compounds and uses thereof
US7247628B2 (en) 2002-12-12 2007-07-24 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
US7348456B2 (en) 2002-12-19 2008-03-25 Merck & Co., Inc. Substituted amides
US7329658B2 (en) 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) 2003-02-10 2007-02-13 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7268133B2 (en) 2003-04-23 2007-09-11 Pfizer, Inc. Patent Department Cannabinoid receptor ligands and uses thereof
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
US7141669B2 (en) 2003-04-23 2006-11-28 Pfizer Inc. Cannabiniod receptor ligands and uses thereof
US7232823B2 (en) 2003-06-09 2007-06-19 Pfizer, Inc. Cannabinoid receptor ligands and uses thereof
AU2005211451B2 (en) 2004-01-28 2010-04-29 F. Hoffmann-La Roche Ag Spiro-benzodioxoles and their use as CB1 antagonists
TW200602314A (en) 2004-05-28 2006-01-16 Tanabe Seiyaku Co A novel pyrrolidine compound and a process for preparing the same
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
EP1812418B1 (en) 2004-11-09 2010-10-27 F. Hoffmann-La Roche AG Dibenzosuberone derivatives
US7632837B2 (en) 2005-06-17 2009-12-15 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid-1 receptor modulators
BRPI0613505A2 (en) 2005-06-30 2011-01-11 Prosidion Ltd gpcr agonists
CL2008000017A1 (en) 2007-01-04 2008-08-01 Prosidion Ltd COMPOUNDS DERIVED FROM NITROGEN AND OXYGEN HETEROCICLES, GPCR AGONISTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF OBESITY, DIABETES, METABOLIC SYNDROME, HYPERLIPIDEMIA, TOLERANCE
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
US20100048632A1 (en) 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine GPCR Agonists
WO2008081208A1 (en) 2007-01-04 2008-07-10 Prosidion Limited Piperidine gpcr agonists
AR064735A1 (en) 2007-01-04 2009-04-22 Prosidion Ltd GPCR AGONISTS AND PHARMACEUTICAL COMPOSITION BASED ON THE COMPOUND
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
TW201021797A (en) 2008-12-04 2010-06-16 Nat Univ Tsing Hua 1,2,3-triazole derivatives as new cannabinoid-1 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
JPH08245315A (en) * 1995-03-16 1996-09-24 Nippon Soda Co Ltd Triazole derivative and pest control agent
MY129541A (en) * 1996-06-25 2007-04-30 Novartis Ag Substituded 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators

Also Published As

Publication number Publication date
ES2192494B1 (en) 2005-02-16
ES2192494A1 (en) 2003-10-01
WO2003082833A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
AU2003215687A1 (en) 1,2,4-triazole derivatives with cannabinoid properties
AU2002349754A1 (en) Novel 1,2,4-triazole compound
AU2003284596A1 (en) Imidazole derivative, process for producing the same, and use
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2002312883A1 (en) Substituted cyclohexane-1,4-diamine derivatives
MXPA03006773A (en) Imidazole derivatives.
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2003243637A1 (en) Cannabinoid receptor agonists
AU2003266333A1 (en) 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
AU2003264207A1 (en) 1,4-substituted cyclohexane derivatives
AU2003248537A1 (en) Bushing
AU2003225846A1 (en) Variable response bushing
AU2002339192A1 (en) 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2003258598A1 (en) Substituted 1,2,3,4-tetrahydroquinoline derivatives
AU2002953019A0 (en) Azole derivatives
AU2003223100A1 (en) 1,2,4-triazol-1-yl-propan-2-ol derivatives as anti-fungal agents
AU2003271171A1 (en) 2,2-DI-SUBSTITUTED 1Alpha,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE
AU2003255737A1 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
AU2001256791A1 (en) 5,6-trans-2-alkylvitamin d derivatives
HK1068617A (en) 5, 6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
AU2002224995A1 (en) Fungicide mixtures based on imidazole derivatives
HK1085209A (en) Novel substituted 2,3-benzodiazepine derivatives
AU2002253121A1 (en) Neorustmicin d derivatives as fungicides
HK1088321A (en) 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase